亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Hepatic imaging response to radioembolization with yttrium-90-labeled resin microspheres for tumor progression during systemic chemotherapy in patients with colorectal liver metastases.

作者
Andrew S. Kennedy,David S. Ball,Steven J. Cohen,Michael Cohn,Douglas M. Coldwell,Alain T. Drooz,Eduardo Ehrenwald,Samir Kanani,Charles W. Nutting,Fred M Moeslein,Samuel Putnam,Steven C. Rose,Michael A. Savin,Sabine Schirm,Navesh K. Sharma,Eric A. Wang
出处
期刊:PubMed [National Institutes of Health]
卷期号:6 (6): 594-604 被引量:16
标识
DOI:10.3978/j.issn.2078-6891.2015.082
摘要

BACKGROUND: To assess response and the impact of imaging artifacts following radioembolization with yttrium-90-labeled resin microspheres ((90)Y-RE) based on the findings from a central independent review of patients with liver-dominant metastatic colorectal cancer (mCRC). METHODS: Patients with mCRC who received (90)Y-RE (SIR-Spheres(®); Sirtex Medical, Sydney, Australia) at nine US institutions between July 2002 and December 2011 were included in the analysis. Tumor response was assessed at baseline and 3 months using either the Response Evaluation Criteria in Solid Tumors (RECIST) version 1.0 or 1.1. For each lesion, known artifacts affecting the interpretation of response (peri-tumoral edema and necrosis) were documented. Survivals (Kaplan-Meier analyses) were compared in responders [partial response (PR)] and non-responders [stable (SD) or progressive disease (PD)]. RESULTS: Overall, 195 patients (mean age 62 years) received (90)Y-RE after a median of 2 (range, 1-6) lines of prior chemotherapy. Using RECIST 1.0 and RECIST 1.1, 7.6% and 6.9% of patients were partial responders, 47.3% and 48.1% had SD, and 55.0% and 55.0% PD, respectively. RECIST 1.0 and RECIST 1.1 showed excellent agreement {Kappa =0.915 [95% confidence interval (CI): 0.856-0.975]}. Peri-tumoral edema was documented in 32.8%, necrosis in 48.1% and both in 57.3% of cases (using RECIST 1.0). Although baseline characteristics were similar in responders and non-responders (P>0.05), responders survived significantly longer in an analysis according to RECIST 1.0: PR median (95% CI) 25.2 (range, 9.2-49.4) months vs. SD 15.8 (range, 9.3-21.1) months vs. PD 7.1 (range, 6.0-9.5) months (P<0.0001). CONCLUSIONS: RECIST 1.0 and RECIST 1.1 imaging responses provide equivalent interpretations in the assessment of hepatic tumors following (90)Y-RE. Radiologic lesion responses at 3 months must be interpreted with caution due to the significant proportion of patients with peri-tumoral edema and necrosis, which may lead to an under-estimation of PR/SD. Nevertheless, 3-month radiologic responses were predictive of prolonged survival.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
null的应助被科研通管家采纳,获得10
1秒前
null的应助被科研通管家采纳,获得10
2秒前
null的应助被科研通管家采纳,获得10
2秒前
呆萌保温杯完成签到,获得积分10
25秒前
水water完成签到 ,获得积分10
32秒前
和谐寻云完成签到,获得积分10
34秒前
dnpl完成签到,获得积分10
36秒前
42秒前
43秒前
诚心的志泽完成签到,获得积分10
45秒前
Richard发布了新的文献求助30
47秒前
47秒前
健康的忘幽完成签到,获得积分10
1分钟前
温不胜的破木吉他完成签到 ,获得积分10
1分钟前
善良士晋完成签到,获得积分10
1分钟前
1分钟前
1分钟前
xiaobai123456完成签到,获得积分10
1分钟前
高高笙完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
null的应助被科研通管家采纳,获得10
2分钟前
渡人舟的应助被科研通管家采纳,获得10
2分钟前
醉熏的孤云完成签到,获得积分10
2分钟前
852的应助被liuqiwei采纳,获得200
2分钟前
2分钟前
彩色白竹完成签到,获得积分10
2分钟前
2分钟前
2分钟前
bwx发布了新的文献求助200
2分钟前
2分钟前
傻傻的含莲完成签到,获得积分10
2分钟前
2分钟前
2分钟前
丘比特的应助被执着念烟采纳,获得10
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158848
求助须知:如何正确求助?哪些是违规求助? 9554492
关于积分的说明 21719333
捐赠科研通 7748419
什么是DOI,文献DOI怎么找? 3427099
关于科研通互助平台的介绍 2552006
邀请新用户注册赠送积分活动 2471370